Who
Surendra K. Ajjarapu
Director
Company insider
Files Form 4 as: Director, Wellgistics Health; Chairman and CEO, Scienture Holdings; CEO and Chairman, Tevogen; Chief Executive Officer, Ocean Biomedical; President, Aemetis.
In numbers
- Trades disclosed
- 35
- Buys
- 2
- Sells
- 1
- Bought
- $130.0M
- Sold
- $28.1B
- Companies
- 5
- Companies where not an officer
- 1
- First trade
- 9 Jan 2008
- Last trade
- 22 Jun 2026
- Last filed
- 25 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jun 2026filed 25 Jun 2026 | Wellgistics HealthHealth Care Distribution | SEC FORM 4 Code X | $500100,000 at $0.005 | filing |
| 22 Jun 2026filed 25 Jun 2026 | Wellgistics Healthoption or derivative · Health Care Distribution | SEC FORM 4 Code X | —100,000 at $0.00 | filing |
| 22 Jun 2026filed 25 Jun 2026 | MEDS DataMeds AIoption or derivative · Health Care Distribution | SEC FORM 4 Code X | —100,000 at $0.00 | filing |
| 22 Jun 2026filed 25 Jun 2026 | MEDS DataMeds AIHealth Care Distribution | SEC FORM 4 Code X | $1,000100,000 at $0.01 | filing |
| 31 Mar 2026filed 25 Jun 2026 | Wellgistics HealthHealth Care Distribution | SEC FORM 4 Code A | $1.0M5,000,000 at $0.20 | filing |
| 31 Mar 2026filed 25 Jun 2026 | Wellgistics Healthoption or derivative · Health Care Distribution | SEC FORM 4 Code A | $5005,000,000 at $0.0001 | filing |
| 31 Mar 2026filed 25 Jun 2026 | MEDS DataMeds AIoption or derivative · Health Care Distribution | SEC FORM 4 Code A | —5,000,000 at $0.00 | filing |
| 31 Mar 2026filed 25 Jun 2026 | MEDS DataMeds AIHealth Care Distribution | SEC FORM 4 Code A | $1.0M5,000,000 at $0.20 | filing |
| 31 Mar 2026filed 23 Apr 2026 | Wellgistics HealthHealth Care Distribution | SEC FORM 4 Code A | $1.0M5,000,000 at $0.20 | filing |
| 31 Mar 2026filed 23 Apr 2026 | Wellgistics Healthoption or derivative · Health Care Distribution | SEC FORM 4 Code A | $50K5,000,000 at $0.01 | filing |
| 31 Mar 2026filed 23 Apr 2026 | MEDS DataMeds AIoption or derivative · Health Care Distribution | SEC FORM 4 Code A | $50K5,000,000 at $0.01 | filing |
| 31 Mar 2026filed 23 Apr 2026 | MEDS DataMeds AIHealth Care Distribution | SEC FORM 4 Code A | $1.0M5,000,000 at $0.20 | filing |
| 21 Mar 2025filed 25 Mar 2025 | MEDS DataMeds AIHealth Care Distribution | SEC FORM 4 Code A | —2,882,247 at $0.00 | filing |
| 21 Mar 2025filed 25 Mar 2025 | MEDS DataMeds AIHealth Care Distribution | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 21 Mar 2025filed 25 Mar 2025 | MEDS DataMeds AIHealth Care Distribution | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 5 Jan 2024filed 28 May 2024 | SCNX Scienture HoldingsPharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 5 Jan 2024filed 16 Jan 2024 | SCNX Scienture HoldingsPharmaceuticals | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 7 Jun 2023filed 21 Jun 2023 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —7,988,889 | filing |
| 7 Jun 2023filed 12 Jun 2023 | TVGN Tevogenoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,988,889 | filing |
| 7 Jun 2023filed 12 Jun 2023 | TVGN Tevogenoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 | filing |
News
SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027SCNX · manilatimes.net · 22 Oct 2026SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential GrowthSCNX · manilatimes.net · 13 Oct 2026Contrasting Scienture (NASDAQ:SCNX) & Gyre Therapeutics (NASDAQ:GYRE)SCNX · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name Surendra K. Ajjarapu; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.